Which statement is accurate about herbal remedies and similar food products?
Herbal remedies pose no danger for drug interactions.
Herbal remedies exhibit a variety of pharmacologic effects.
Herbal remedies have been rigorously tested by the FDA.
Herbal remedies can be safely used during pregnancy.
The Correct Answer is B
Choice A rationale
Herbal remedies contain a diverse array of pharmacologically active compounds, such as alkaloids, glycosides, and essential oils, which can interact with conventional drugs. These interactions can lead to increased or decreased drug metabolism, altered drug effects, or increased toxicity (e.g., St. John's Wort inducing drug-metabolizing enzymes).
Choice B rationale
Herbal remedies contain complex mixtures of natural substances that often interact with various biological targets in the body, exhibiting a range of effects. These effects can include anti-inflammatory, antimicrobial, sedative, or circulatory actions, similar to conventional drugs, depending on their active phytoconstituents and concentration.
Choice C rationale
In the United States, the Food and Drug Administration (FDA) regulates herbal remedies as dietary supplements, not as drugs. This means they are not subjected to the rigorous pre-market testing, standardization, and efficacy proof required for prescription and over-the-counter medications.
Choice D rationale
Many herbal remedies have unknown safety profiles during pregnancy due to a lack of rigorous clinical testing. Some herbs are known to be teratogenic, abortifacient, or may stimulate uterine contractions (e.g., Black Cohosh, Pennyroyal), making their use during gestation potentially hazardous and generally discouraged unless specifically approved by a healthcare provider.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["B","C","D"]
Explanation
Choice A rationale
The Food and Drug Administration (FDA) Emergency Use Authorization (EUA) for nirmatrelvir/ritonavir (Paxlovid) specifies that it is authorized for use in adults and pediatric patients who are 12 years of age and older and weigh at least 40 kg. Stating only the age is insufficient, as the weight criterion is also essential for safe and effective dosing in the pediatric population, ensuring appropriate pharmacokinetics and minimizing toxicity risks.
Choice B rationale
Nirmatrelvir/ritonavir (Paxlovid) must be initiated as soon as possible after diagnosis of COVID-19 and within 5 days of symptom onset. This timeframe is crucial because the drug works by inhibiting the SARS-CoV-2 main protease, which is most effective during the early viral replication phase before the viral load peaks and significant organ damage occurs, thus maximizing therapeutic benefit.
Choice C rationale
A rash, especially one that is severe or progresses, can be a sign of a hypersensitivity reaction to nirmatrelvir or ritonavir, such as Stevens-Johnson syndrome (SJS) or Toxic Epidermal Necrolysis (TEN). The patient must report this immediately so the medication can be discontinued and appropriate supportive care initiated to prevent life-threatening complications.
Choice D rationale
Dysgeusia (altered taste sensation), often described as a metallic taste, is a frequently reported adverse effect of nirmatrelvir/ritonavir (Paxlovid). This occurs due to the drug's excretion in saliva. Informing the patient proactively helps to manage expectations and ensure adherence to the medication regimen despite this temporary and bothersome side effect.
Choice E rationale
Significant weight gain is not a recognized common or serious adverse reaction of nirmatrelvir/ritonavir (Paxlovid). Common side effects include dysgeusia, diarrhea, hypertension, and myalgia. Weight loss might be seen in the context of severe COVID-19 infection, but not as an expected drug effect.
Correct Answer is B
Explanation
Choice A rationale
Immunoglobulin A (IgA) is the predominant antibody found in mucosal secretions like saliva, tears, breast milk, and gastrointestinal fluid, providing local mucosal immunity against ingested or inhaled pathogens. While vital for defense, IgA does not typically trigger the systemic mast cell degranulation and massive mediator release characteristic of anaphylaxis.
Choice B rationale
Immunoglobulin E (IgE) is the antibody that mediates Type I hypersensitivity reactions, including anaphylaxis. IgE is bound to the surface of mast cells and basophils. Upon re-exposure to a specific antigen (allergen), cross-linking of these IgE molecules triggers a massive, rapid release of pre-formed mediators, such as histamine and leukotrienes, causing the severe, systemic symptoms like profound vasodilation and bronchoconstriction.
Choice C rationale
Immunoglobulin G (IgG) is the most abundant antibody in plasma, providing long-term humoral immunity and crossing the placenta to confer passive immunity to a fetus. It is a primary mediator of Type II and Type III hypersensitivity reactions. Although it can activate the complement cascade, IgG does not play the principal role in the immediate, IgE-driven pathogenesis of anaphylaxis.
Choice D rationale
Immunoglobulin M (IgM) is the largest antibody, often existing as a pentamer, and is the first antibody produced during a primary immune response, primarily located in the blood and lymph fluid. It is highly effective at activating the complement system and agglutination but is not the specific key mediator responsible for initiating the rapid mast cell degranulation that defines anaphylaxis.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.